I-124 EVuzamitide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for I-124 EVuzamitide, covering 2025-12-19 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis [Phase 3]